Michael Rassner Selected Research

Michael Rassner Research Topics

6	Neoplasms (Cancer) 03/2023 - 10/2019
4	Multiple Myeloma 01/2021 - 11/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2023 - 10/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Residual Neoplasm 01/2022
1	Inflammation (Inflammations) 10/2021
1	Hemolysis 01/2021
1	Human Influenza (Influenza) 01/2021
1	Smoldering Multiple Myeloma 01/2021
1	Paraproteinemias (Monoclonal Gammopathy) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Anaplastic Thyroid Carcinoma 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Hemolytic Anemia 11/2020

2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2020
2	Circulating Tumor DNAIBA 01/2022 - 08/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024
1	Imatinib Mesylate (Gleevec)FDA Link 03/2023
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	CytokinesIBA 10/2021
1	Oncostatin MIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Decitabine FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2021
1	pembrolizumabIBA 01/2021
1	venetoclaxIBA 01/2021
1	daratumumabIBA 01/2021
1	lenvatinibIBA 01/2021
1	prolinedithiocarbamate (PDTC)IBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	carfilzomibIBA 01/2021
1	eculizumab FDA Link 01/2021
1	Dapsone FDA Link 11/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020

2	Therapeutics 01/2021 - 01/2021
1	Blood Component Removal (Apheresis) 01/2021
1	Transplantation 01/2021
1	Stem Cell Transplantation 01/2021